CASE REPORT
Year : 2021 | Volume
: 12 | Issue : 1 | Page : 31--33
Post-COVID-19 guillain-barre syndrome: A distinct neurological entity
Ritika Sud1, Jyoti Verma2, Shubham Goswami1, Niharika Aggarwal1, Anil Gurtoo1
1 Department of Medicine, Lady Hardinge Medical College & SSK Hospital, New Delhi, India
2 Department of Medicine, Bhagwan Mahavir Hospital, New Delhi, India
Correspondence Address:
Dr. Ritika Sud
Department of Medicine, LHMC, Shaheed Bhagat Singh Marg, New Delhi - 110 001
India
SARS-CoV-2, the causative agent for COVID-19, originated in China in the fall of 2019 and soon became a pandemic engulfing the entire world, presenting with a myriad of presentations from asymptomatic to severe disease with acute respiratory distress syndrome and multiple organ dysfunction and severe inflammatory response. Little is understood about the new virus and its pathogenesis, and it is too early to ascertain its long-term sequelae at this point in time. New associations and clinical problems keep appearing with the new virus and thus we also got to encounter three cases of acute inflammatory demyelinating polyneuropathy (AIDP) in patients following COVID-19 infection. This case series aims to convey clinicians that AIDP can be seen in patients with COVID-19, particularly during the recovery phase, and thus not to miss it as postviral fatigue and malaise.
How to cite this article:
Sud R, Verma J, Goswami S, Aggarwal N, Gurtoo A. Post-COVID-19 guillain-barre syndrome: A distinct neurological entity.Indian J Med Spec 2021;12:31-33
|
How to cite this URL:
Sud R, Verma J, Goswami S, Aggarwal N, Gurtoo A. Post-COVID-19 guillain-barre syndrome: A distinct neurological entity. Indian J Med Spec [serial online] 2021 [cited 2023 Mar 26 ];12:31-33
Available from: http://www.ijms.in/article.asp?issn=0976-2884;year=2021;volume=12;issue=1;spage=31;epage=33;aulast=Sud;type=0 |
|
|
|
